Cancer incidence in patients with schizophrenia or bipolar disorder: A nationwide population-based study in Taiwan, 1997-2009

Schizophrenia Bulletin

Volumn 39, Issue 2, 2013, Pages 407-416

  Lin, Gen Min ^a,b   Chen, Yu Jung ^a,b   Kuo, De Jhen ^c   Jaiteh, Lamin E S ^d   Wu, Yi Chung ^a,b   Lo, Tzu Shun ^a   Li, Yi Hwei ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c TZU CHI COLLEGE OF TECHNOLOGY   (Taiwan)

^d Royal Victoria Teaching Hospital Gambia   (Gambia)

Author keywords

bipolar disorder; cancer; schizophrenia; standardized incidence ratio

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL PATIENT; ONSET AGE; PRIORITY JOURNAL; SCHIZOPHRENIA; STANDARDIZED INCIDENCE RATIO; TAIWAN;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; BIPOLAR DISORDER; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS; SCHIZOPHRENIA; SEX DISTRIBUTION; TAIWAN; YOUNG ADULT;

EID: 84874551432     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbr162     Document Type: Article

References (40)

1. Commissioners in Lunacy for England and Wales.Annual Report. London, UK: HMSO; 1909.
2. Mortensen PB. The incidence of cancer in schizophrenic patients. J Epidemiol Community Health. 1989;43:43-47. (Pubitemid 19076739)
3. Gulbinat W, Dupont A, Jablensky A, et al. Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries. Br J Psychiatry Suppl. 1992;18:75-83.
4. Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, Lonnqvist J. Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry. 2001; 58:573-578. (Pubitemid 32523737)
5. Barak Y, Achiron A, Mandel M, Mirecki I, Aizenberg D. Reduced cancer incidence among patients with schizophrenia. Cancer. 2005;104:2817-2821. (Pubitemid 41798293)
6. Grinshpoon A, Barchana M, Ponizovsky A, et al. Cancer in schizophrenia: is the risk higher or lower? Schizophr Res. 2005;73:333-341. (Pubitemid 40093897)
7. Hippisley-Cox J, Vinogradova Y, Coupland C, Parker C. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study. Arch Gen Psychiatry. 2007;64:1368-1376. (Pubitemid 350223554)
8. Dalton SO, Mellemkjaer L, Thomassen L, Mortensen PB, Johansen C. Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993. Schizophr Res. 2005;75:315-324. (Pubitemid 40693064)
9. Catts VS, Catts SV, O'Toole BI, Frost AD. Cancer incidence in patients with schizophrenia and their first-degree relatives-a meta-analysis. Acta Psychiatr Scand. 2008;117:323-336. (Pubitemid 351502440)
10. Malzberg B. Rates of discharge and rates of mortality among first admissions to the New York civil state hospitals. Ment Hyg. 1952;36:104-120.
11. Katz J, Kunofsky S, Patton RE, Allaway NC. Cancer mortality among patients in New York mental hospitals. Cancer. 1967;20:2194-2199.
12. Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748-752.
13. BarChana M, Levav I, Lipshitz I, et al. Enhanced cancer risk among patients with bipolar disorder. J Affect Disord. 2008;108:43-48. (Pubitemid 351444799)
14. Jeste DV, Symonds LL, Harris MJ, Paulsen JS, Palmer BW, Heaton RK. Nondementia nonpraecox dementia praecox? Late-onset schizophrenia. Am J Geriatr Psychiatry. 1997; 5:302-317. (Pubitemid 27483910)
15. Tran-Johnson TK, Krull AJ, Jeste DV. Late life schizophrenia and its treatment: pharmacologic issues in older schizophrenic patients. Clin Geriatr Med. 1992;8:401-410.
16. Breier A, Schreiber JL, Dyer J, Pickar D. Course of illness and predictors of outcome in chronic schizophrenia: implications for pathophysiology. Br J Psychiatry Suppl. 1992;18:38-43.
17. Steiner J, Bielau H, Brisch R, et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res. 2008;42:151-157. (Pubitemid 350061255)
18. van Berckel BN, Bossong MG, Boellaard R, et al. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry. 2008;64:820-822.
19. HansonDR,Gottesman II.Theories of schizophrenia: a geneticinflammatory- vascular synthesis. BMC Med Genet. 2005;6:7.
20. Pert CB, Knight JG, Laing P, MarkwellMA. Scenarios for a viral etiology of schizophrenia. Schizophr Bull. 1988;14:243-7.
21. Duramad P, Tager IB, Holland NT. Cytokines and other immunological biomarkers in children's environmental health studies. Toxicol Lett. 2007;172:48-59. (Pubitemid 47126222)
22. Hildesheim A, AppleRJ, Chen CJ, et al. Association ofHLAclass I and II alleles and extended haplotypeswith nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst. 2002;94:1780-1789. (Pubitemid 36004354)
23. Carrington M, Wang S, Martin MP, et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med. 2005;201:1069-1075. (Pubitemid 40524675)
24. Demirhan O, Tastemir D. Chromosome aberrations in a schizophrenia population. Schizophr Res. 2003;65:1-7. (Pubitemid 37410397)
25. Catts VS, Catts SV. Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? Schizophr Res. 2000;41:405-415. (Pubitemid 30109597)
26. Cui DH, Jiang KD, Jiang SD, Xu YF, Yao H. The tumor suppressor adenomatous polyposis coli gene is associated with susceptibility to schizophrenia. Mol Psychiatry. 2005;10:669-677. (Pubitemid 40961737)
27. Mortensen PB. Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients. Acta Psychiatr Scand. 1992;85:390-393.
28. Dalton SO, Johansen C, Poulsen AH, et al. Cancer risk among users of neuroleptic medication: a population-based cohort study. Br J Cancer. 2006;95:934-939. (Pubitemid 44498111)
29. Chou FH, Tsai KY, Su CY, Lee CC. The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res. 2011;129:97-103.
30. Tworoger SS, Hankinson SE. Prolactin and breast cancer risk. Cancer Lett. 2006;243:160-169. (Pubitemid 44485858)
31. Liao DL, Yang JY, Lee SM, Chen H, Tsai SJ. Smoking in chronic schizophrenic inpatients in taiwan. Neuropsychobiology. 2002;45:172-175. (Pubitemid 34827802)
32. Chien YC, Chen JY, Liu MY, et al. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med. 2001;345:1877-1882.
33. Harkins L, Volk AL, Samanta M, et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet. 2002;360:1557-1563. (Pubitemid 35356371)
34. Guo JJ. Schizophrenia associated with increased risk of colon cancer but reduced risk of respiratory cancer. Evid Based Ment Health. 2008;11:93.
35. Sonvilla G, Allerstorfer S, Heinzle C, et al. Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration. Br J Cancer. 2010;102:1145-56.
36. Hashimoto K, Shimizu E, Komatsu N, et al. Increased levels of serum basic fibroblast growth factor in schizophrenia. Psychiatry Res. 2003;120:211-218. (Pubitemid 38366048)
37. Chang TT, Lin H, Yen YS, Wu HL. Hepatitis B and hepatitis C among institutionalized psychiatric patients in Taiwan. J Med Virol. 1993;40:170-173. (Pubitemid 23169747)
38. Massard C, Fizazi K. Targeting continued androgen receptor signaling in prostate cancer. Clin Cancer Res. 2011;17:3876-3883.
39. JoffeH, Cohen LS, Suppes T, et al. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiatry. 2006;59:1078-1086. (Pubitemid 43849652)
40. Howard LM, Barley EA, Davies E, et al. Cancer diagnosis in people with severe mental illness: practical and ethical issues. Lancet Oncol. 2010;11:797-804.